BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21778271)

  • 1. Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation.
    Yu CR; Mahdi RR; Oh HM; Amadi-Obi A; Levy-Clarke G; Burton J; Eseonu A; Lee Y; Chan CC; Egwuagu CE
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6978-86. PubMed ID: 21778271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of suppressor of cytokine signaling in retina of experimental autoimmune uveoretinitis].
    Wang H; Zhou ZC; Peng XY; Zhao M
    Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):876-82. PubMed ID: 19176113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis.
    He C; Yu CR; Sun L; Mahdi RM; Larkin J; Egwuagu CE
    J Autoimmun; 2015 Aug; 62():31-8. PubMed ID: 26094775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells.
    Liu X; Mameza MG; Lee YS; Eseonu CI; Yu CR; Kang Derwent JJ; Egwuagu CE
    Diabetes; 2008 Jun; 57(6):1651-8. PubMed ID: 18356406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells.
    Jiang HR; Muckersie E; Robertson M; Forrester JV
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1598-607. PubMed ID: 12657598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
    Okunuki Y; Usui Y; Nagai N; Kezuka T; Ishida S; Takeuchi M; Goto H
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2255-61. PubMed ID: 19136706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.
    Cunningham MA; Austin BA; Li Z; Liu B; Yeh S; Chan CC; Anglade E; Velagaleti P; Nussenblatt RB
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):249-55. PubMed ID: 18708627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of cytokine signaling 1 (SOCS1) mitigates anterior uveitis and confers protection against ocular HSV-1 infection.
    Yu CR; Hayashi K; Lee YS; Mahdi RM; Shen DF; Chan CC; Egwuagu CE
    Inflammation; 2015 Apr; 38(2):555-65. PubMed ID: 24993154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor.
    Zhang L; Ma J; Takeuchi M; Usui Y; Hattori T; Okunuki Y; Yamakawa N; Kezuka T; Kuroda M; Goto H
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2109-17. PubMed ID: 20007828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms.
    Agarwal RK; Horai R; Viley AM; Silver PB; Grajewski RS; Su SB; Yazdani AT; Zhu W; Kronenberg M; Murray PJ; Rutschman RL; Chan CC; Caspi RR
    J Immunol; 2008 Apr; 180(8):5423-9. PubMed ID: 18390724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of spontaneous uveoretinitis development by non-immunopathogenic peptide immunization.
    Takeuchi M; Kezuka T; Inoue H; Sakai J; Usui M; Takahashi T; Taguchi O
    Eur J Immunol; 1998 May; 28(5):1578-86. PubMed ID: 9603463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.
    Yadav UC; Shoeb M; Srivastava SK; Ramana KV
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8033-41. PubMed ID: 21900376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity.
    Zhang X; Ren X; Li G; Jiao C; Zhang L; Zhao S; Wang J; Han ZC; Li X
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3143-52. PubMed ID: 21296818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective function of invariant natural killer T cells in the relapse of experimental autoimmune uveoretinitis.
    Tajiri N; Kato T; Satoh M; Iizuka M; Taniguchi M; Kitaichi N; Iwabuchi K
    Exp Eye Res; 2021 Feb; 203():108406. PubMed ID: 33347870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance.
    Bagenstose LM; Agarwal RK; Silver PB; Harlan DM; Hoffmann SC; Kampen RL; Chan CC; Caspi RR
    J Immunol; 2005 Jul; 175(1):124-30. PubMed ID: 15972638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS1 Mimetic Peptide Suppresses Chronic Intraocular Inflammatory Disease (Uveitis).
    He C; Yu CR; Mattapallil MJ; Sun L; Larkin Iii J; Egwuagu CE
    Mediators Inflamm; 2016; 2016():2939370. PubMed ID: 27703302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.